LINC01376 promotes nasopharyngeal carcinoma tumorigenesis by competitively binding to the SP1 / miR ‐4757/ IGF1 axis
IUBMB Life · 2023
DOI: 10.1002/iub.2721 ↗Kurz gefasst
Fachartikel in der Zeitschrift IUBMB Life, 2023. Verfasst von Yi Peng und 10 weiteren Autor:innen. Beteiligte Einrichtung: The Affiliated Cancer Hospital of Nanjing Medical University & Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research, Nanjing, China. Hauptthemen laut MEDLINE: MicroRNAs, Nasopharyngeal Neoplasms, RNA, Long Noncoding. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Jiangsu Province.
Abstract (Originalsprache)
The long non‐coding RNA (lncRNA)–microRNA (miRNA) interaction network plays a crucial part in the pathogenesis of nasopharyngeal carcinoma (NPC). Here, we discovered a relationship between LINC01376 and miR‐4757 in NPC tumor development. First, LINC01376 was abnormally overexpressed in NPC tissues and cells, and its elevated expression was associated with advanced clinical stage and shorter distant metastasis‐free survival time. Moreover, biological experiments showed that LINC01376 facilitated the proliferative, invasive, and migratory abilities of NPC cells in vitro and in vivo. Mechanistically, bioinformatics and RT‐qPCR assays revealed that LINC01376 knockdown upregulated the expression level of downstream miR‐4757, including miR‐4757 primary transcript (pri‐miR‐4757) and mature miR‐4757. Furthermore, LINC01376 competitively sponged the transcription factor SP1 and reduced its enrichment in the upstream promoter region of miR‐4757 to repress miR‐4757 expression. Finally, insulin‐like growth factor 1(IGF1) was identified as the target of miR‐4757. Rescue experiments indicated that LINC01376 accelerated NPC cell proliferation, migration, and invasion through the miR‐4757‐5p/IGF1 axis. In conclusion, the SP1/miR‐4757/IGF1 axis, which is regulated by LINC01376 in NPC deterioration and metastasis, is expected to provide new insights into the molecular mechanism of NPC carcinogenesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Affiliated Cancer Hospital of Nanjing Medical University & Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research, Nanjing, China.
- Department of Pathology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, China.
- Department of Radiotherapy, The Affiliated BenQ Hospital of Nanjing Medical University, Nanjing, China.
ORCID-Profile: Xia He
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Jiangsu Province
Zitieren
APA
Peng, Y., Zhang, Y., Liu, Y., Dong, Z., Wang, T., Peng, F., Di, W., Zong, D., Du, M., Zhou, H., & He, X. (2023). LINC01376 promotes nasopharyngeal carcinoma tumorigenesis by competitively binding to the SP1 / miR ‐4757/ IGF1 axis. IUBMB Life. https://doi.org/10.1002/iub.2721
Vancouver
Peng Y, Zhang Y, Liu Y, Dong Z, Wang T, Peng F, et al. LINC01376 promotes nasopharyngeal carcinoma tumorigenesis by competitively binding to the SP1 / miR ‐4757/ IGF1 axis. IUBMB Life. 2023. doi:10.1002/iub.2721
BibTeX
@article{Peng2023,
author = {Peng, Yi and Zhang, Yujie and Liu, Yatian and Dong, Zhen and Wang, Tingting and Peng, Fanyu and Di, Wenyi and Zong, Dan and Du, Mingyu and Zhou, Hongping and He, Xia},
title = {LINC01376 promotes nasopharyngeal carcinoma tumorigenesis by competitively binding to the SP1 / miR ‐4757/ IGF1 axis},
journal = {IUBMB Life},
year = {2023},
doi = {10.1002/iub.2721}
}
EUVIMED